09/11/2025
Two conferences. One message.
The future of Obesity Care is not a pill… it is a pathway.
Today I had the privilege to speak at ASI Punjab Chapter alongside Dr. Sanjay Bdada, HOD Endocrinology, PGIMER Chandigarh, debating one of the most discussed topics in healthcare today:
Bariatric Surgery vs GLP-1 Drugs
And later at Harmony 2025, Jalandhar, invited by my dear friend and senior endocrinologist
Dr. Vipin Talwar, the discussion continued, and the hall echoed the same sentiment.
GLP-1 medicines have their role.
But they are a part of the journey, not the destination.
Bariatric Surgery is not just about weight loss.
It is about metabolic reset.
It addresses insulin resistance, gut hormones, appetite regulation, liver health, cardiac risk, mobility, mental well-being – and most importantly, long-term sustainability.
Weight loss is not just about kilos.
It is about reclaiming life.
When science, clinical judgment and compassion come together, the results are transformational — not temporary.
Proud to represent the surgical perspective.
Proud to speak for patients who deserve more than short-term solutions.
Proud to keep the conversation scientific, respectful, and meaningful.
We are not fighting GLP-1 drugs.
We are fighting obesity.
